Surgical removal of visceral fat reverses hepatic insulin resistance

Diabetes

Volumn 48, Issue 1, 1999, Pages 94-98

  Barzilai, Nir ^a   She, Li ^a   Liu, Bing Qian ^a   Vuguin, Patricia ^a   Cohen, Pinchas ^b   Wang, Jiali ^a   Rossetti, Luciano ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE 6 PHOSPHATASE; INSULIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP);

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; CONTROLLED STUDY; GLUCONEOGENESIS; HYPERINSULINEMIA; INSULIN RESISTANCE; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; SUBCUTANEOUS FAT; TRANSCRIPTION REGULATION; VISCERA;

ADIPOSE TISSUE; ANIMALS; BODY COMPOSITION; GENE EXPRESSION; GLUCOSE-6-PHOSPHATASE; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; LEPTIN; LIVER; MALE; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SKIN PHYSIOLOGY; TUMOR NECROSIS FACTOR-ALPHA; VISCERA;

EID: 0032938719     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.1.94     Document Type: Article

References (38)

1. Peiris AN, Struve MF, Mueller RA, Lee MB, Kissebah AH: Glucose metabolism in obesity: influence of body fat distribution. J Clin Endocrinol Metab 67:760-767, 1988
2. Colberg SR, Simoneau JA, Thaete FL, Kelley DE: Skeletal muscle utilization of free fatty acids in women with visceral obesity. J Clin Invest 95:1427-1428, 1995
3. Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ: Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 45:633-638, 1996
4. Coon PJ, Rogus EM, Drinkwater D. Muller DC, Goldberg AP: Role of body fat distribution in the decline in insulin sensitivity and glucose tolerance with age. J Clin Endocrinol Metab 75: 1125-1132, 1992
5. O'Shaughnessy IM, Myers TJ, Stepniakowski K, Nazzaro P, Kelly TM, Hoffmann RG, Egan BM, Kissebah AH: Glucose metabolism in abdominally obese hypertensive and normotensive subjects. Hypertension. 26:186-192, 1995
6. Bjorntorp P: Portal adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 10:493-496, 1990
7. Williamson J, Kreisberg RA, Pelts PW: Mechanisms for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. Proc Natl Acad Sci U S A 56:247-254, 1966
8. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271:665-668, 1996
9. Argaud D, Zhang Q, Pan W, Maitra S, Pilkis SJ, Lange AJ: Regulation of rat liver glucose-6-phosphatase gene expression in different nutritional and hormonal states: gene structure and 5′-flanking sequence. Diabetes 45:1563-1571, 1996
10. Gabbay RA, Sutherland C, Gnudi L, Kahn BB, O'Brien RM, Granner DK, Flier JS: Insulin regulation of phosphoenolpyruvate carboxykinase gene expression does not require activation of the Ras/mitogen-activated protein kinase. J Biol Chem 271:1890-1897, 1996
11. O'Brien RM, Noisin EL, Suwanichkul A, Yamasaki T, Lucas PC, Wang JC, Powell DR, Granner DK: Hepatic nuclear factor 3- and hormone-regulated expression of the phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein 1 genes. Mol Cell Biol 15:1747-1758, 1995
12. Lee PD, Giudice LC, Conover CA, Powell DR: Insulin-like growth factor binding protein-1: recent findings and new directions. Proc Soc Exp Biol Med 216:319-357, 1997
13. Cichy SB, Uddin S, Damlkovich A, Guo S, Klippel A, Unterman TG: Protein kinase B/Akt mediates effects of insulin on hepatic insulin-like growth factor-binding protein-1 gene expression through a conserved insulin response sequence. J Biol Chem 273:6482-6487, 1998
14. Mogul HR, Marshall M, Frey M, Burke HB, Wynn PS, Wilker S, Southern AL, Gambert SR: Insulin like growth factor-binding protein-1 as a marker for hyperinsulinemia in obese menopausal women. J Clin Endocrinol Metab 81:4492-4495, 1996
15. Benbassat CA, Maki KC, Unterman TG: Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures. J Clin Endocrinol Metab 82:1484-1491, 1997
16. Travers SH, Labarta JI, Gargosky SE, Rosenfeld RG, Jeffers BW, Eckel RH: Insulin-like growth factor binding protein-1 levels are strongly associated with insulin sensitivity and obesity in early pubertal children. J Clin Endocrinol Metab 83:1935-1939, 1998
17. Nyomba BL, Berard L, Murphy LJ: Free insulin-like growth factor I (IGF-I) in healthy subjects: relationship with IGF-binding proteins and insulin sensitivity. J Clin Endocrinol Metab 82:2177-2181, 1997
18. Morris DV, Falcone T: The relationship between insulin sensitivity and insulin-like growth factor-binding protein-1. Gynecol Endocrinol 10:407-412, 1996
19. Shmueli E, Miell JP, Stewart M, Alberti KG, Record CO: High insulin-like growth factor binding protein 1 levels in cirrhosis: link with insulin resistance. Hepatology 24:127-133, 1996
20. Attia N, Tamborlane WV, Heptulla R, Maggs D, Grozman A, Sherwin RS, Caprio S: The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity. J Clin Endocrinol Metab 83:1467-1471, 1998
21. Lemne C, Brismar K: Insulin-like growth factor binding protein-1 as a marker of the metabolic syndrome: a study in borderline hypertension. Blood Press 7:89-95, 1998
22. Janssen JA, Stolk RP, Pols HA, Grobbee DE, Lamberts SW: Serum total IGF-I, free IGF-I, and IGFBP-I levels in an elderly population: relation to cardiovascular risk factors and disease. Arterioscler Thromb Vase Biol 18:277-282, 1998
23. Barzilai N, Rossetti L: Age-related changes in body composition are associated with hepatic insulin resistance in conscious rats. Am J Physiol 270:E930-E936, 1996
24. Barzilai N, Banerjee S, Hawkins M, Chen W, Rossetti L: Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat. J Clin Invest 101:1353-1361, 1998
25. Barzilai N, Hawkins M, Massilon D, Vuguin P, Rossetti L: Leptin selectively decreases visceral adiposity and enhances peripheral and hepatic insulin action. J Clin Invest 100:3105-3110, 1997
26. Wang J, Liu R, Hawkins M, Barzilai N, Rossetti L: A nutrient sensing pathway regulates leptin gene expression in muscle and fat. Nature 393:684-688, 1998
27. Cohen P, Peele DM, Hintz RL, Rosenfeld RG: Insulin-like growth factor axis abnormalities in cultures of prostate stromal cells from patients with benign prostatic hypertrophy. J Clin Endocrinol Metab 79:1410-1415, 1994
28. Rebrin K, Steil GM, Mittelman SD, Bergman RN: Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J Clin Invest 98:741-749, 1996
29. Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM: Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 83:1168-1173, 1989
30. Massillon D, Angelov I, Barzilai N, Hawkins M, Prus-Wertheimer D, Rossetti L: Induction of hepatic glucose-6-phosphatase gene expression by lipid infusion. Diabetes 46:153-157, 1997
31. Solberg P, Cohen P: The role of the insulin-like growth factor binding proteins and their proteases in modulating IGF action. Endocrinol Metabol Clin North Am 25:591-614, 1996
32. Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S: Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes 46:342-347, 1997
33. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95:2409-2415, 1995
34. Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, Hotamisligil GS, Spiegelman BM: Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134:264-270, 1994
35. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I: Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 46:860-867, 1997
36. Flier JS, Cook KS, Usher P, Spiegelman BM: Severely impaired adipsin expression in genetic and acquired obesity. Science 237:405-408, 1987
37. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF: A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270:26746-26749, 1995
38. Saladin R, De Vos P, Guerre-Millo M, Leturque A, Girard J, Staels B, Auwerx J: Transient increase in obese gene expression after food intake or insulin administration. Nature 377:527-529, 1995